Transcriptomic signature : a spatially resolved analysis of the nephron structures in chronic kidney disease

Presented at: Cell Biology 2020
Speaker

Abstract

Chronic kidney disease (CKD) is a global health threat, affecting over 10% of the world population, including an estimated 37 million Americans. Importantly, glomerular diseases account for 70% of all the CKD. To date, no effective treatment for CKD exists, except that of dialysis or transplantation, which are associated with comorbidities, complications, and poor quality of life. Both of these treatment options present an enormous economic burden on the healthcare system, not to mention that transplantation is not even readily available due to a shortage of donor organs. Therefore, new breakthrough knowledge to generate more potent therapies for CKD is needed.

In the glomerulus, podocytes and endothelial cells together with the glomerular basement membrane form the glomerular filtration apparatus, and damage to any one of its components leads to kidney disease. Many different theories of disease progression have emerged over time, ranging from podocyte depletion hypothesis to recent evidence for metabolic dysfunction. However, none of these claims have been able to clearly elucidate the exact path of progression, which has ultimately resulted in failed attempts for treatment.

To better understand disease mechanisms and the integrated function of the glomerular and tubular cell types we applied spatial transcriptome analysis tools to investigate patterns of gene expression in kidney biopsies from healthy patient and patients affected with Alport syndrome (AS), focal segmental glomerulosclerosis (FSGS), and membranous nephropathy (MN). Single glomeruli and tubular and interstitial regions were selected and served as areas of interest for the generation of the Whole Transcriptome Atlas.

Results showed distinct separation between tubular and glomerular regions both in healthy as well as in diseased kidneys. Transcripts typical of glomerular cells were highly enriched in the glomeruli and not in the tubules. Marked differences were observed between glomeruli from AS, FSGS, MN and healthy control samples. Measurable differences in gene expression were also evident between the different etiologies possibly highlighting the mechanistic differences amongst them.

In conclusion, this strategy enables us to answer unresolved questions about glomerular and tubular damage during CKD and repair mechanisms and will help in the development of new therapies to halt disease progression. The knowledge gained from these studies might be applicable to other forms of CKD.

Learning Objectives:

1. To understand the basic principles of special transcriptomics

2. To learn the basic principles for interpreting spatial transcriptomic data


Show Resources
You May Also Like
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
AUG 16, 2022 11:00 AM PDT
AUG 16, 2022 11:00 AM PDT
Date: August 16, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing pers...
NOV 09, 2022 8:00 AM PST
NOV 09, 2022 8:00 AM PST
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...
Loading Comments...
Show Resources